Compounds > vidarabine phosphate

vidarabine phosphate and Glioma

vidarabine phosphate has been researched along with Glioma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, TC; Hong, JS; Kasahara, N; Lai, YH; Li, YF; Logg, CR; Parker, WB; Sorscher, EJ; Tai, CK; Wang, W1
Allan, PW; Hong, JS; Parker, WB; Sorscher, EJ; Waud, WR1
Allan, PW; Bebok, Z; Hong, JS; Levasseur, DN; McPherson, SA; Moore, BA; Parker, WB; Secrist, JA; Sorscher, EJ; Townes, TM; Waud, WR; Wen, H1
Allan, PW; Bennett, LL; Gilbert, KS; Gillespie, GY; King, SA; Montgomery, JA; Parker, WB; Secrist, JA; Sorscher, EJ; Waud, WR; Wells, AH1
Brown, LD; Cascino, TL; Dinapoli, RP; Everson, LK; Marschke, RF; Morton, RF; O'Fallon, JR1

Other Studies

5 other study(ies) available for vidarabine phosphate and Glioma

ArticleYear
Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
    Cancer gene therapy, 2010, Volume: 17, Issue:9

    Topics: Animals; Antimetabolites, Antineoplastic; Escherichia coli; Genetic Therapy; Genetic Vectors; Glioma; Green Fluorescent Proteins; Humans; Injections, Intralesional; Injections, Subcutaneous; Mice; Mice, Nude; Prodrugs; Purine-Nucleoside Phosphorylase; Retroviridae; Vidarabine Phosphate

2010
In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.
    Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:2

    Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Bystander Effect; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Escherichia coli; Genetic Therapy; Genetic Vectors; Glioma; Humans; Injections, Intralesional; Mice; Mice, Nude; Prodrugs; Purine-Nucleoside Phosphorylase; Transfection; Transplantation, Heterologous; Vidarabine Phosphate

2012
Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.
    Cancer research, 2004, Sep-15, Volume: 64, Issue:18

    Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Drug; Escherichia coli; Genetic Therapy; Genetic Vectors; Glioma; Humans; Lentivirus; Mice; Mice, Nude; Moloney murine leukemia virus; Purine-Nucleoside Phosphorylase; Transfection; Vidarabine Phosphate; Xenograft Model Antitumor Assays

2004
In vivo gene therapy of cancer with E. coli purine nucleoside phosphorylase.
    Human gene therapy, 1997, Sep-20, Volume: 8, Issue:14

    Topics: Animals; Antimetabolites, Antineoplastic; Escherichia coli; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Prodrugs; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Retroviridae; Vidarabine Phosphate

1997
Evaluation of fludarabine phosphate in patients with recurrent glioma.
    American journal of clinical oncology, 1988, Volume: 11, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Brain Neoplasms; Drug Administration Schedule; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Vidarabine Phosphate

1988